MedPath

Health Effects of Recreational Soccer in Type 2 Diabetic Men

Not Applicable
Completed
Conditions
Metabolic Syndrome
Hypertension
Obesity
Type 2 Diabetes
Interventions
Other: soccer exercise or continued daily lifestyle
Registration Number
NCT01636349
Lead Sponsor
University of Copenhagen
Brief Summary

The present study investigates the effects of recreational soccer in type 2 diabetic men in regard to muscular, cardiovascular adaptations and glycaemic control. 12 men participate in 6 month structured recreational soccer training and 10 men act as control with no change in lifestyle. Testing consisting of fasting blood samples, muscle biopsies, Dexa-scans, echocardiography, maximal oxygen consumption, Yo-Yo interval test, bloodpressure, Resting heart rate, and endothelial function (Itamar, Endopat)will be performed at baseline, after 12 and 24 weeks, respectively.

The study examines the hypothesis that the high-intensity aerobic work profile combined with a high anaerobic turnover from the nature of soccer (accelerations, decelerations, turns, sudden stops) will improve glycaemic control, muscle and cardiac function and taken together will improve the overall health profile in type 2 diabetic men

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
22
Inclusion Criteria
  • Type 2 diabetes diagnosed
  • 35-60 years old men
Exclusion Criteria
  • Smoker
  • Ischaemic heart Disease
  • Congestive heart failure
  • Joint or limp pains to an extent where recreational soccer can not be performed.
  • Apoplexia.
  • Anticoagulant therapy (aspirin accepted)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Recreational soccer trainingsoccer exercise or continued daily lifestyle12 men participate in recreational soccer training for 6 months
Primary Outcome Measures
NameTimeMethod
muscular adaptationsData analysis after baseline, 12 and 24 weeks

muscle biopsies are obtaned from the vastus lateralis muscle at baseline, after 12 and 24 weeks, respectively

Cardiac adaptationsAnalysis of data at baseline, 12 and 24 weeks

All participants are examined with 2d- echocardiography, speckletracking, strain and colordoppler

Secondary Outcome Measures
NameTimeMethod
glycaemic controlData analysis after baseline, 12 and 24 weeks

HbA1c, insulin and C-peptide are meassured at baseline, after 12 and 24 weeks, respectively

Vascular functionData analysis after baseline, 12 and 24 weeks

All subjects are examined with peripheral arterial tonometri (endopat). Plasma samples and muscle biopsies are analyzed for relevant markers of vascular function

Trial Locations

Locations (1)

University of Copenhagen

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath